Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99per week for the first 24weeks
Just $1.99per week for the first 24weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Decreasing anxiety, expense and suboptimal care of cancer patients is the goal of a new website tracking the inconsistent availability of cancer drugs by province across the country.

Launched by the Cancer Advocacy Coalition of Canada, the free site cancerdrugaccess.ca reveals the access to and funding for drugs for current cancer treatment, as well as their usage by type of cancer and when they were approved by Health Canada. There is no information for the territories.

"It's going to be a game changer," said Dr. David Saltman, staff medical oncologist at the B.C. Cancer Agency.

Story continues below advertisement

The Canadian Cancer Society estimates 187,600 cases of cancer are expected to be diagnosed in 2013. The leading cancers for men are prostrate, lung and colorectal; for women, the most common are breast, lung and colorectal.

The website, which is still under construction, brings to light the inequities between provinces. For example, one drug may only be available during certain stages of treatment, only to certain patient groups, or in limited centres. Not all cancer drug information is publicly available, and some governments and/or cancer agencies have just not come to a conclusion about whether they will fund a certain drug.

Saltman said the hope is to crowdsource further information for the site from patients and cancer advocacy groups. Once someone sends information in, it will be verified before being added to the site.

The goal of this resource is for patients, families of patients, physicians, pharmacists, hospital administrators and health ministry officials to have a place to go to compare access to these drugs across the country. Saltman hopes that the site eventually makes provinces aware of where they are lacking in comparison with other provinces.

"Making these things public is – maybe embarrassing is not the word – but it's a wake-up call," he said.

Saltman said it's not uncommon for people to move to a different province if they need a drug that isn't funded in the province they currently live in. They must be living in the new province for three months before they can apply to get the drug, so many people quit their jobs and move across the country.

Saltman said he hopes the inequity in cancer drug access could become a focal point during elections.

Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies